AnalystsColleen Kusy
Colleen Kusy's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Bottom 5%
#4882 out of 5121 analysts
Average Return
-11.29%
Win Rate
32%16 out of 50
Risk vs Reward
Poor
Good

Colleen Kusy's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Iveric Bio IncISEE
+150.13%$14.94$37.37
2022-09-07 -
2023-05-04
Buy
Ocular Therapeutix IncOCUL
+149.31%$3.61$9.00
2023-09-14 -
2024-09-13
Buy
Surface Oncology IncSURF
+85.12%$0.58$1.07
2023-05-04 -
2023-09-07
Buy
Oculis Holding AgOCS
+66.02%$11.92$19.79
2024-06-11 -
2025-06-10
Buy
Coherus Oncology IncCHRS
+64.42%$0.82$1.34
2024-11-08 -
2025-11-07
Buy

Colleen Kusy Analyst Color

Get additional color on Colleen Kusy's coverage of popular stocks

Colleen Kusy's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Nuvalent IncNUVL
3Buy$158.00+50.53%Maintains
15 days ago
Cogent Biosciences IncCOGT
1Hold$34.00-12.78%Maintains
23 days ago
Apellis Pharmaceuticals IncAPLS
13Buy$52.00+151.69%Maintains
a month ago
Ocular Therapeutix IncOCUL
5Buy$24.00+113.33%Maintains
2 months ago
Climb Bio IncCLYM
1Buy$9.00+448.78%Initiates Coverage On
4 months ago
Enliven Therapeutics IncELVN
3Buy$52.00+152.92%Maintains
6 months ago
Agenus IncAGEN
4Hold$6.00+43.88%Maintains
6 months ago
Oculis Holding AgOCS
4Buy$41.00+118.20%Maintains
9 months ago
Coherus Oncology IncCHRS
5Buy$6.00+417.24%Maintains
a year ago
Spyre Therapeutics IncSYRE
2Buy$65.00N/AMaintains
a year ago
Mersana Therapeutics IncMRSN
4Hold$75.00N/AMaintains
a year ago
Oric Pharmaceuticals IncORIC
1Buy$25.00N/AReiterates
2 years ago
Surface Oncology IncSURF
5Buy$6.00N/AMaintains
3 years ago
Iveric Bio IncISEE
3Hold$40.00N/ADowngrades
3 years ago
Harpoon Therapeutics IncHARP
1HoldN/AN/ADowngrades
3 years ago
Aveo Pharmaceuticals IncAVEO
1Hold$15.00N/ADowngrades
3 years ago
Karyopharm Therapeutics IncKPTI
1Buy$210.00N/AMaintains
3 years ago
Iovance Biotherapeutics IncIOVA
2Buy$34.00N/AMaintains
4 years ago
Sab Biotherapeutics IncSABS
1Buy$230.00N/AInitiates Coverage On
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.